Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 4/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 7/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.39 |
| ▸ | BTK | Q06187 | 2/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22356324 | 0.83 | THRB (0.56) | MTNR1AMTNR1BBTKTHRB | |
| SCHEMBL1055225 | 0.83 | BCHE (0.56) | BCHEACHEMTNR1AMTNR1BTHRB | |
| SCHEMBL13777528 | 0.83 | MTNR1A (0.48) | BCHEACHEMTNR1AMTNR1BTHRB | |
| SCHEMBL22356393 | 0.82 | BCHE (0.40) | BCHEACHEMTNR1AMTNR1BEGFR | |
| SCHEMBL11987123 | 0.80 | KMT2A (0.41) | BCHEACHEMTNR1AMTNR1BEGFR | |
| SCHEMBL22356374 | 0.77 | THRB (0.43) | BCHEBTKTHRBLMNAKMT2A | |
| SCHEMBL3996164 | 0.77 | KMT2A (0.53) | BCHEACHEMTNR1AMTNR1BTHRB | |
| SCHEMBL15067727 | 0.76 | MTNR1A (0.48) | BCHEACHEMTNR1AMTNR1BTHRB | |
| SCHEMBL9915698 | 0.76 | BCHE (0.44) | BCHEACHEMTNR1AMTNR1BEGFR | |
| SCHEMBL9915803 | 0.76 | BCHE (0.44) | BCHEACHEMTNR1AMTNR1BEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TYR, CRY2, CRY1 | BCHE 4810/4885ACHE 4570/4885MTNR1A 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.